{
  "id": 12378590,
  "title": "Alpha Cognition to Present New ZUNVEYL® (Benzgalantamine) Clinical and Real-World Data at ASCP Annual Meeting and NEI Fall Congress",
  "url": "https://urgent.news/2026/10/06/alpha-cognition-to-present-new-zunveyl-benzgalantamine-clinical-and",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-06T12:48:14.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/pmn/business-wire-news-releases-pmn/alpha-cognition-to-present-new-zunveyl-benzgalantamine-clinical-and-real-world-data-at-ascp-annual-meeting-and-nei-fall-congress"
  },
  "original_language": "en",
  "account": null,
  "summary": "Presentations will highlight data on cognition, function, neuropsychiatric symptoms, sleep, gastrointestinal tolerability, treatment patterns and psychotropic medication utilization in Alzheimer’s disease VANCOUVER, British Columbia & DALLAS — Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition” or the “Company”), a commercial-stage biopharmaceutical company focused on developing therapies for…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}